The primary purpose of this study is to compare the long-term efficacy and safety of
desvenlafaxine succinate sustained release versus placebo in adults with Major Depressive
Disorder, using a randomized withdrawal design. Randomized withdrawal means that after
receiving desvenlafaxine succinate sustained release for a predetermined period of time,
subjects will be selected by chance to either continue receiving the study drug or to be
withdrawn from the study drug and receive placebo for the remainder of their participation
in the trial. Subjects will not know to which group they have been assigned.
The study consists of an up to 14-day screening period followed by an 8-week open-label
period in which subjects will knowingly receive 50 mg/day of desvenlafaxine succinate
sustained release. Subjects who do not respond to treatment, demonstrating no significant
change in their depressive symptoms, will be withdrawn from participation at the end of this
period. Responding subjects will receive an additional 3 months of open-label desvenlafaxine
succinate sustained release at the same dose. Subjects with stable response to treatment at
the conclusion of this 3 month period will be randomized to either desvenlafaxine succinate
sustained release at 50 mg/day or placebo in a blinded manner for an additional 6 months or
until symptoms of depression return. Following discontinuation at any point after enrollment
in the study, subjects will receive two weeks of follow-up monitoring, including one week of
blinded taper with 25 mg/day of desvenlafaxine succinate sustained release treatment for any
subjects who have been taking desvenlafaxine succinate sustained release prior to
discontinuation. Subjects assigned to placebo will receive a blinded placebo taper.
Following taper, subjects will be evaluated for one additional week to monitor safety.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Pfizer Investigational Site, Santiago 7530193, Chile
Pfizer Investigational Site, Santiago 7630000, Chile
Pfizer Investigational Site, Santiago 8330838, Chile
Pfizer Investigational Site, Rijeka 51000, Croatia
Pfizer Investigational Site, Zagreb 10000, Croatia
Pfizer Investigational Site, Tallinn 12618, Estonia
Pfizer Investigational Site, Tallinn, Estonia
Pfizer Investigational Site, Tartu 51003, Estonia
Pfizer Investigational Site, Voru 65608, Estonia
Pfizer Investigational Site, Vöru 65608, Estonia
Pfizer Investigational Site, Espoo 02600, Finland
Pfizer Investigational Site, Helsinki 00100, Finland
Pfizer Investigational Site, Joensuu 80100, Finland
Pfizer Investigational Site, Kuopio 70110, Finland
Pfizer Investigational Site, Seinajoki 60100, Finland
Pfizer Investigational Site, Tampere 33100, Finland
Pfizer Investigational Site, Turku 20100, Finland
Pfizer Investigational Site, Caen 14000, France
Pfizer Investigational Site, Dole 39100, France
Pfizer Investigational Site, Douai 59500, France
Pfizer Investigational Site, Orvault 44700, France
Pfizer Investigational Site, Rennes 35000, France
Pfizer Investigational Site, Liepaja LV-3400, Latvia
Pfizer Investigational Site, Sigulda LV-2150, Latvia
Pfizer Investigational Site, Sigulda, Latvia
Pfizer Investigational Site, Strenci 4730, Latvia
Pfizer Investigational Site, Kaunas 3000, Lithuania
Pfizer Investigational Site, Kaunas LT-50185, Lithuania
Pfizer Investigational Site, Vilius, Lithuania
Pfizer Investigational Site, Vilnius 10204, Lithuania
Pfizer Investigational Site, Vilnius LT-09112, Lithuania
Pfizer Investigational Site, Vilnius LT-10204, Lithuania
Pfizer Investigational Site, Szczecin 71-460, Poland
Pfizer Investigational Site, Torun 87-100, Poland
Pfizer Investigational Site, Tuszyn 95-080, Poland
Pfizer Investigational Site, Wroclaw 50-227, Poland
Pfizer Investigational Site, Zuromin 09-300, Poland
Pfizer Investigational Site, Brasov 500123, Romania
Pfizer Investigational Site, Bucharest 041914, Romania
Pfizer Investigational Site, Bucuresti 010825, Romania
Pfizer Investigational Site, Bucuresti 041914, Romania
Pfizer Investigational Site, Cluj Napoca 400012, Romania
Pfizer Investigational Site, Bojnice 972 01, Slovakia
Pfizer Investigational Site, Bratislava 820 07, Slovakia
Pfizer Investigational Site, Liptovsky Mikulas 031 23, Slovakia
Pfizer Investigational Site, Michalovce 071 01, Slovakia
Pfizer Investigational Site, Rimavska Sobota 979 12, Slovakia
Pfizer Investigational Site, Trencin 91101, Slovakia
Pfizer Investigational Site, Durban 3630, South Africa
Pfizer Investigational Site, Paarl 7646, South Africa
Pfizer Investigational Site, Edmonton, Alberta T6L 6W6, Canada
Pfizer Investigational Site, Medicine Hat, Alberta T1B 4E7, Canada
Pfizer Investigational Site, Medellin, Antioquia, Colombia
Pfizer Investigational Site, Barranquilla, Atlantico, Colombia
Pfizer Investigational Site, Kelowna, British Columbia V1Y 1Z9, Canada
Pfizer Investigational Site, Vancouver, British Columbia V6Z 2L4, Canada
Pfizer Investigational Site, Beverly Hills, California 90210, United States
Pfizer Investigational Site, Encino, California 91316, United States
Pfizer Investigational Site, Los Alamitos, California 90720, United States
Pfizer Investigational Site, Orange, California 92868, United States
Pfizer Investigational Site, Upland, California 91786, United States
Pfizer Investigational Site, Aurora, Colorado 80045, United States
Pfizer Investigational Site, Bogota, Cundinamarca, Colombia
Pfizer Investigational Site, Craiova, Dolj 200317, Romania
Pfizer Investigational Site, Jacksonville, Florida 32256, United States
Pfizer Investigational Site, South Miami, Florida 33143, United States
Pfizer Investigational Site, St. Petersburg, Florida 33702, United States
Pfizer Investigational Site, St. Petersburg, Florida 33716, United States
Pfizer Investigational Site, Atlanta, Georgia 30328, United States
Pfizer Investigational Site, Smyrna, Georgia 30080, United States
Pfizer Investigational Site, Hoffman Estates, Illinois 60169, United States
Pfizer Investigational Site, Rockville, Maryland 20852, United States
Pfizer Investigational Site, Bathurst, New Brunswick E2A 4X7, Canada
Pfizer Investigational Site, New York, New York 10024, United States
Pfizer Investigational Site, New York, New York 10128, United States
Pfizer Investigational Site, Rochester, New York 14618, United States
Pfizer Investigational Site, Dayton, Ohio 45408, United States
Pfizer Investigational Site, Burlington, Ontario L7R 4E2, Canada
Pfizer Investigational Site, Ottawa, Ontario K1G 4G3, Canada
Pfizer Investigational Site, Toronto, Ontario M9W 4L6, Canada
Pfizer Investigational Site, Portland, Oregon 97210, United States
Pfizer Investigational Site, Skorzewo, Poznan 60-185, Poland
Pfizer Investigational Site, Gatineau, Quebec J9A 1K7, Canada
Pfizer Investigational Site, Pointe-Claire, Quebec H9R 4S3, Canada
Pfizer Investigational Site, Sherbrooke, Quebec J1H 4J6, Canada
Pfizer Investigational Site, Bucamaranga, Santander, Colombia
Pfizer Investigational Site, San Antonio, Texas 78247, United States
Pfizer Investigational Site, Seattle, Washington 98104, United States
Pfizer Investigational Site, Cape Town, Western Cape 7530, South Africa